Search

Search Constraints

You searched for: Author/Creator Ortoncelli, Michela

Search Results

1. A 52‐week update of a multicentre Italian real‐world experience on effectiveness and safety of dupilumab in adolescents with moderate‐to‐severe atopic dermatitis. (18th October 2022)

4. Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice?. (6th February 2023)

9. Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real‐life experience in a tertiary referral centre. (27th May 2021)

10. Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study. (19th May 2022)